Lisa Wiesmüller Selected Research

Lisa Wiesmüller Research Topics

Disease

31	Neoplasms (Cancer) 04/2022 - 07/2002
10	Breast Neoplasms (Breast Cancer) 01/2021 - 04/2007
6	Genomic Instability 01/2021 - 04/2010
5	Leukemia 01/2021 - 01/2015
5	Carcinogenesis 10/2017 - 04/2008
5	Ataxia Telangiectasia (Louis Bar Syndrome) 01/2017 - 02/2008
3	Carcinoma (Carcinomatosis) 04/2022 - 08/2008
3	Ovarian Neoplasms (Ovarian Cancer) 01/2021 - 01/2013
2	Adenocarcinoma 01/2021 - 10/2017
2	Neoplasm Metastasis (Metastasis) 04/2020 - 08/2019
2	Circulating Neoplastic Cells 04/2020 - 08/2019
2	Chromosomal Instability (Chromosome Stability) 11/2017 - 01/2017
2	Chromosome Aberrations (Chromosome Abnormalities) 01/2017 - 05/2014
2	Chromosome Breakage 01/2017 - 01/2015
1	AIDS-Related Complex (ARC) 01/2022
1	familial Prostate cancer 01/2021
1	Aneuploidy (Aneuploid) 01/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 01/2021
1	Microcephaly 01/2019
1	Hyperpigmentation 01/2019
1	Amenorrhea 01/2017
1	Primary Ovarian Insufficiency 01/2017
1	Lung Neoplasms (Lung Cancer) 07/2016
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2016
1	Head and Neck Neoplasms (Head and Neck Cancer) 04/2015
1	Squamous Cell Carcinoma of Head and Neck 04/2015
1	Fanconi Anemia (Fanconi's Anemia) 04/2015
1	Infections 01/2015
1	Familial Breast Cancer 03/2013
1	Genetic Predisposition to Disease (Genetic Predisposition) 05/2012
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2011
1	Premature Aging 04/2010
1	Nijmegen Breakage Syndrome 04/2010
1	Glioblastoma (Glioblastoma Multiforme) 10/2009

Drug/Important Bio-Agent (IBA)

22	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 08/2002
17	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2021 - 04/2007
11	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2002
6	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2021 - 08/2008
5	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 04/2022 - 10/2014
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2013
3	PlatinumIBA 01/2021 - 07/2016
3	Phosphotransferases (Kinase)IBA 10/2017 - 11/2011
2	olaparibIBA 04/2022 - 01/2021
2	DDTIBA 10/2021 - 12/2020
2	Pharmaceutical PreparationsIBA 01/2021 - 01/2021
2	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2021 - 01/2017
2	Biological ProductsIBA 01/2020 - 01/2013
2	ChromatinIBA 01/2017 - 04/2008
2	Small Interfering RNA (siRNA)IBA 03/2015 - 03/2008
2	CarcinogensIBA 05/2014 - 02/2008
2	EnzymesIBA 04/2007 - 08/2002
1	Mitochondrial DNA (mtDNA)IBA 01/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022
1	Protein Isoforms (Isoforms)IBA 10/2021
1	MicroRNAs (MicroRNA)IBA 01/2021
1	Peptide LibraryIBA 01/2021
1	Carboplatin (JM8)FDA LinkGeneric 01/2021
1	Peptides (Polypeptides)IBA 01/2021
1	enhanced green fluorescent proteinIBA 01/2021
1	Carrier Proteins (Binding Protein)IBA 04/2020
1	eribulin FDA Link 04/2020
1	Hormones (Hormone)IBA 04/2020
1	eprenetapoptIBA 01/2020
1	ParaffinIBA 01/2020
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020
1	Cell-Free Nucleic AcidsIBA 01/2020
1	GonadotropinsIBA 01/2017
1	Antineoplastic Agents (Antineoplastics)IBA 07/2016
1	NucleotidesIBA 07/2016
1	proteasome maturation proteinIBA 03/2016
1	Nuclear Proteins (Protein, Nuclear)IBA 03/2016
1	UbiquitinIBA 01/2016
1	Ligases (Synthetase)IBA 01/2016
1	Transcription Factors (Transcription Factor)IBA 01/2016
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 01/2016
1	Codon (Codons)IBA 10/2015
1	Lamin Type B (Lamin B)IBA 03/2015
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2015
1	AnthracyclinesIBA 01/2015
1	ORALIT (ORS)IBA 05/2012
1	Protein CIBA 02/2012
1	A-Form DNA (A-DNA)IBA 09/2011
1	Oncogene Proteins (Oncogene Protein)IBA 01/2011
1	ChemokinesIBA 04/2010
1	Histone Deacetylases (Histone Deacetylase)IBA 04/2010
1	Sirtuin 1IBA 04/2010
1	NF-KappaB Inhibitor alphaIBA 10/2009
1	Intercalating AgentsIBA 10/2009
1	NF-kappa B (NF-kB)IBA 10/2009
1	Cyclin A1IBA 09/2008
1	Caffeine (No Doz)FDA LinkGeneric 03/2008

Therapy/Procedure

15	Therapeutics 01/2021 - 08/2008
5	Drug Therapy (Chemotherapy) 01/2021 - 04/2015
1	Induction Chemotherapy 01/2021
1	Aftercare (After-Treatment) 01/2020
1	Adjuvant Chemotherapy 11/2016
1	Radiotherapy 01/2015
1	Transplantation 01/2015